Last updated: 17 June 2019 at 2:54am EST

Robert D Jr Shallish Net Worth




The estimated Net Worth of Robert D Jr Shallish is at least $4.89 Milhão dollars as of 31 March 2015. Robert Shallish owns over 17,350 units of Conmed stock worth over $4,887,029 and over the last 21 years Robert sold CNMD stock worth over $0.

Robert Shallish CNMD stock SEC Form 4 insiders trading

Robert has made over 15 trades of the Conmed stock since 2011, according to the Form 4 filled with the SEC. Most recently Robert exercised 17,350 units of CNMD stock worth $1,272,970 on 31 March 2015.

The largest trade Robert's ever made was exercising 21,600 units of Conmed stock on 5 March 2013 worth over $405,864. On average, Robert trades about 1,639 units every 17 days since 2003. As of 31 March 2015 Robert still owns at least 66,608 units of Conmed stock.

You can see the complete history of Robert Shallish stock trades at the bottom of the page.



What's Robert Shallish's mailing address?

Robert's mailing address filed with the SEC is , , , , .

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti, eDirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



Complete history of Robert Shallish stock trades at Conmed

Acionista maioritário
Trans.
Transação
Preço total
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $876,002
31 Mar 2015
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $326,874
29 Oct 2014
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $144,126
28 Aug 2014
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $426,800
11 Aug 2014
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $260,420
1 Jun 2014
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $159,904
7 Jun 2013
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $171,236
1 Jun 2013
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $250,300
28 May 2013
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $405,864
5 Mar 2013
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $266,100
23 Nov 2012
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $104,360
1 Jun 2012
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $21,792
17 May 2012
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $388,350
20 Mar 2012
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $77,364
1 Jun 2011
Robert D Jr Shallish
Vice President/Finance/CFO
Exercício de opção $44,304
16 May 2011


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: